Skip to main content
. 2023 Dec 8;14:1287367. doi: 10.3389/fimmu.2023.1287367

Figure 5.

Figure 5

NK cell phenotype in hepatitis patients. (A) Frequency of circulating CD3-CD16+CD56dim and CD3-CD16-CD56bright NK cells in healthy donors (HD) (n=29), chronic hepatitis B/D (cHBV/cHDV) (n=5) and resolved cHBV/cHDV patients among PBMCs (n=9) (bars represent the mean frequency of cells +/- SEM). (B) Expression of CD69 or TRAIL on circulating CD3-CD16+CD56dim and CD3-CD16- CD56bright NK cells in cHBV (n=12) and cHBV/cHDV (n=4) patients (bars represent the mean frequency of positive cells +/- SEM). Levels of significance: *p<0.05, **p<0.01, ****p<0.0001 (student’s t-test).